Fatal heart failure associated with CoQ10 and multiple OXPHOS deficiency in a child with propionic acidemia
Konstantina Fragaki1, Aline Cano, Jean-François Benoist
1Department of Medical Genetics, Archet 2 Hospital, Nice Teaching Hospital, France.
Insights
Propionic acidemia (PA) can cause secondary coenzyme Q(10) deficiency, leading to oxidative phosphorylation disorders and heart failure. Early detection of this coenzyme Q(10) defect is crucial for potential treatment and improved outcomes.
Area of Science:
- Biochemistry
- Genetics
- Pediatric Medicine
Background:
- Propionic acidemia (PA) is a metabolic disorder.
- Secondary respiratory chain deficiency is a proposed mechanism for PA complications.
- Oxidative phosphorylation (OXPHOS) defects may contribute to PA's long-term effects.
Observation:
- A child with PA presented with acute heart failure without metabolic stress.
- Liver assays revealed reduced quinone-dependent OXPHOS activities (complex I+III, complex II+III).
- Restoration of complex II+III activity with exogenous ubiquinone indicated coenzyme Q(10) deficiency.
Findings:
- This is the first report of a coenzyme Q(10) functional defect and OXPHOS deficiency in a child with PA.
- The observed OXPHOS defect was independent of acute metabolic decompensation.
- Insufficient tissue prevented direct coenzyme Q(10) level measurement.
Implications:
- Prompt identification of coenzyme Q(10) defects in PA is vital.
- CoQ(10) deficiency is a treatable OXPHOS disorder.
- Further research is needed to confirm the efficacy of coenzyme Q(10) therapy for PA-related cardiac complications.
Abstract:
The role of a secondary respiratory chain deficiency as an additional mechanism to intoxication, leading to development of long-term energy-dependent complications, has been recently suggested in patients with propionic acidemia (PA). We show for the first time a coenzyme Q(10) (CoQ(10)) functional defect accompanied by a multiple organ oxidative phosphorylation (OXPHOS) deficiency in a child who succumbed to acute heart failure in the absence of metabolic stress. Quinone-dependent activities in the liver (complex I+III, complex II+III) were reduced, suggesting a decrease in electron transfer related to the quinone pool. The restoration of complex II+III activity after addition of exogenous ubiquinone to the assay system suggests CoQ(10) deficiency. Nevertheless, we disposed of insufficient material to perform direct measurement of CoQ(10) content in the patient's liver. Death occurred before biochemical diagnosis of OXPHOS deficiency could be made. However, this case highlights the usefulness of rapidly identifying CoQ(10) defects secondary to PA since this OXPHOS disorder has a good treatment response which could improve heart complications or prevent their appearance. Nevertheless, further studies will be necessary to determine whether CoQ(10) treatment can be useful in PA complications linked to CoQ(10) deficiency.
Related Concept Videos
Heart Failure II: Pathophysiology
Inborn Errors of Metabolism
Pathophysiology of Heart Failure
Acute Respiratory Failure-III
Heart Failure III: Clinical Manifestations
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...


